SBTi Verifies GenScript Biotech Corp's Carbon Emission Reduction Goals, Marking a Major Sustainability Milestone!

SBTi Verifies GenScript Biotech Corp's Carbon Emission Reduction Goals, Marking a Major Sustainability Milestone!

PISCATAWAY, N.J., Feb. 18, 2025 /PRNewswire/ -- GenScript Biotech Corp, a global leader in life sciences R&D and manufacturing services, today announced that it is committing to aggressive carbon emission reduction targets. These targets have...

LG Display Targets Gaming Market with OLED Monitor Panel featuring World's Best Picture Quality

LG Display Targets Gaming Market with OLED Monitor Panel featuring World's Best Picture Quality

SEOUL, South Korea, Feb. 18, 2025 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today that it has officially begun mass production of a 45-inch Gaming OLED monitor panel with ultra-high 5K2K resolution....

Razor Labs Enters Subscription Agreement with SIMEC Mining Following Initial Pilot Phase

Razor Labs Enters Subscription Agreement with SIMEC Mining Following Initial Pilot Phase

SYDNEY, Feb. 18, 2025 /PRNewswire/ -- Razor Labs (TASE: RZR), a leader in AI-driven predictive maintenance solutions, announced today its new subscription agreement with SIMEC Mining, a major industrial and mining operator in South Australia....

MANHATTAN ASSOCIATES AUSTRALIA CERTIFIED AS A GREAT PLACE TO WORK FOR 2025

MANHATTAN ASSOCIATES AUSTRALIA CERTIFIED AS A GREAT PLACE TO WORK FOR 2025

SYDNEY, Feb. 18, 2025 /PRNewswire/ -- Manhattan Associates Inc. (NASDAQ: MANH) is proud to announce that its Australian office has once again been recognised as a 'great place to work' through the Great Place to Work® Trust Index© Survey. This...

Vantage Markets Recognized at the Global Brands Magazine Awards 2025

Vantage Markets Recognized at the Global Brands Magazine Awards 2025

PORT VILA, Vanuatu, Feb. 17, 2025 /PRNewswire/ -- Vantage Markets is honored to announce its recognition at the Global Brands Magazine (GBM) Awards 2025, where it has been acknowledged for – "Best CFD Broker, APAC 2025" and "Best Forex Affiliate...

Hong Kong SMEs face rising business costs and rapidly evolving cyber risks, while AI is thought to significantly impact business productivity, finds QBE Hong Kong annual SME survey

Hong Kong SMEs face rising business costs and rapidly evolving cyber risks, while AI is thought to significantly impact business productivity, finds QBE Hong Kong annual SME survey

Almost 60% of survey respondents say increased costs and reduced profitability is a challenge, with about half finding cash flow and access to funding a challenge. To counter these issues, many continue to implement a wide range of measures,...

EBANX secures In-Principle Approval for Major Payment Institution license from Monetary Authority of Singapore, amplifying global payments reach

EBANX secures In-Principle Approval for Major Payment Institution license from Monetary Authority of Singapore, amplifying global payments reach

The Payment Service Provider strengthens its global operations and accelerates APAC expansion after obtaining In-Principle Approval for a Singapore Major Payment Institution license. The APAC region represents 39% of the fintech's total processed...

Mingzhu Receives Nasdaq Delisting Notice Subject to Hearing Request

Mingzhu Receives Nasdaq Delisting Notice Subject to Hearing Request

SHENZHEN, China, Feb. 15, 2025 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ ), an elite provider of logistics and transportation services to businesses, today announced that on February 13, 2025, it...

Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases

Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases

BOSTON, Feb. 14, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Bambusa), a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders, today announced the successful completion of its...

Kexing Biopharm Obtained IND Approval for Its Self-developed GB05 from U.S. FDA

Kexing Biopharm Obtained IND Approval for Its Self-developed GB05 from U.S. FDA

SHENZHEN, China, Feb. 14, 2025 /PRNewswire/ -- Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05, Human Interferon α1b Inhalation Solution, a self-developed product by...

  • 1
  • ...
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • ...
  • 108
  • menu
    menu